Choi et al., 2015 - Google Patents
A microengineered pathophysiological model of early-stage breast cancerChoi et al., 2015
View PDF- Document ID
- 5527128453912424573
- Author
- Choi Y
- Hyun E
- Seo J
- Blundell C
- Kim H
- Lee E
- Lee S
- Moon A
- Moon W
- Huh D
- Publication year
- Publication venue
- Lab on a Chip
External Links
Snippet
A mounting body of evidence in cancer research suggests that the local microenvironment of tumor cells has a profound influence on cancer progression and metastasis. In vitro studies on the tumor microenvironment and its pharmacological modulation, however, are often …
- 206010006187 Breast cancer 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Choi et al. | A microengineered pathophysiological model of early-stage breast cancer | |
Yang et al. | Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing | |
Ozkan et al. | In vitro vascularized liver and tumor tissue microenvironments on a chip for dynamic determination of nanoparticle transport and toxicity | |
Gupta et al. | A novel scaffold-based hybrid multicellular model for pancreatic ductal adenocarcinoma—toward a better mimicry of the in vivo tumor microenvironment | |
JP5602718B2 (en) | Three-dimensional microfluidic platform and method of use | |
US20200115667A1 (en) | Vascularized microfluidic platforms | |
Sato et al. | Recent progress in the development of microfluidic vascular models | |
JP2018533931A (en) | In vitro method and apparatus for modeling cancer metastasis | |
Hu et al. | Vascularized tumor spheroid-on-a-chip model verifies synergistic vasoprotective and chemotherapeutic effects | |
US11577002B2 (en) | Bioengineered vascular network | |
US20210147778A1 (en) | Biomimetic device | |
US20200270557A1 (en) | Human in vitro orthotopic and metastatic models of cancer | |
Mi et al. | 3D bioprinting tumor models mimic the tumor microenvironment for drug screening | |
Seaman et al. | Recent advances in cancer-on-a-chip tissue models to dissect the tumour microenvironment | |
Agrawal et al. | The tumour microenvironment modulates cancer cell intravasation | |
Jung et al. | Advances in 3D vascularized tumor-on-a-Chip technology | |
Sukanya et al. | Differential osteo-specific invasion of patient-derived cancer cells in a microfluidic co-culture model | |
Sotra et al. | A vascularized crypt-patterned colon model for high-throughput drug screening and disease modelling | |
Shin et al. | Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling | |
Velliou et al. | Biomaterial-based in vitro models for pancreatic cancer | |
Baka et al. | Cancer-on-chip technology: Current applications in major cancer types, challenges and future prospects | |
Hall et al. | Mimicking blood and lymphatic vasculatures using microfluidic systems | |
KR102611554B1 (en) | Blood Brain Barrier-On-a-Chip | |
Komez et al. | A two-compartment bone tumor model to investigate interactions between healthy and tumor cells | |
Gomillion et al. | Engineered Composites for 3D Mammary Tissue Systems |